Literature DB >> 25343622

Effects of dendritic cells from hepatitis B virus transgenic mice-stimulated autologous lymphocytes on hepatitis B virus replication: a study on the impact of specific sensitized effector cells on in vitro virus replication.

Zhong-Yang Shen1, Wei-Ping Zheng, Tao Liu, Yang Yang, Hong-Li Song.   

Abstract

The objective of this study was to explore the effects of dendritic cells (DCs) from hepatitis B virus (HBV) transgenic mice-stimulated autologous lymphocytes on in vitro HBV replication. DCs from HBV transgenic mice were induced to maturity by lipopolysaccharide, followed by incubation with hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg) in vitro. Mature DCs and autologous lymphocytes were co-stimulated to form specific sensitized immune effector cells (IEC), which were then co-cultured with the human hepatoma cell line HepG2.2.15. Changes in morphology and activity of hepatocytes were then observed, as well as analysis of changes in liver enzyme, and HBV DNA and inflammatory cytokine levels in the culture supernatant. Intracellular HBV DNA and covalently closed circular DNA (cccDNA) concentration were measured by real-time polymerase chain reaction. Co-stimulation by mature DCs and IEC showed no impact on the morphology and liver enzyme expression level of HepG2.2.15 cells, but the supernatant HBV DNA and intracellular HBV DNA and cccDNA levels decreased significantly compared with those cells co-cultured with immature DCs. Secretion of inflammatory cytokines in the supernatant showed that when HBV DNA was highly expressed, the concentration of IFN-γ and IL-2 decreased, while IL-10 increased. Contrastingly, when HBV DNA had low expression, the concentration of IFN-γ and IL-2 increased and IL-10 decreased. Co-stimulation of HBV-related antigen-induced mature DCs and autologous lymphocytes showed inhibitory effects on ex vivo HBV replication, and cytokines were suggested to mediate this effect.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25343622      PMCID: PMC4333252          DOI: 10.1089/vim.2014.0053

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  32 in total

Review 1.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Adoptive transfer of immunity to HBV in liver transplant patients: a step forward toward the proof of concept for therapeutic vaccination or a transient immunologic phenomenon?

Authors:  Daniel Shouval
Journal:  Liver Transpl       Date:  2007-01       Impact factor: 5.799

Review 3.  Managing HBV in patients with impaired immunity.

Authors:  Karsten Wursthorn; Heiner Wedemeyer; Michael P Manns
Journal:  Gut       Date:  2010-06-04       Impact factor: 23.059

4.  Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.

Authors:  Jens Rosenau; Nazanin Hooman; Johannes Hadem; Kinan Rifai; Matthias J Bahr; Gunnar Philipp; Hans L Tillmann; Juergen Klempnauer; Christian P Strassburg; Michael P Manns
Journal:  Liver Transpl       Date:  2007-03       Impact factor: 5.799

Review 5.  Epidemiology and prevention of hepatitis B.

Authors:  Miriam J Alter
Journal:  Semin Liver Dis       Date:  2003-02       Impact factor: 6.115

6.  Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches.

Authors:  A W Avolio; E Nure; M Pompili; R Barbarino; M Basso; L Caccamo; S Magalini; S Agnes; M Castagneto
Journal:  Transplant Proc       Date:  2008 Jul-Aug       Impact factor: 1.066

7.  Double-dose double-phase use of second generation hepatitis B virus vaccine in patients after living donor liver transplantation: Not an effective measure in transplant recipients.

Authors:  Noriyo Yamashiki; Yasuhiko Sugawara; Sumihito Tamura; Junichi Kaneko; Yuichi Matsui; Junichi Togashi; Norihiro Kokudo; Masao Omata; Masatoshi Makuuchi
Journal:  Hepatol Res       Date:  2008-08-28       Impact factor: 4.288

8.  In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.

Authors:  Patrizia Carotenuto; Andrè Artsen; Hubert G Niesters; Albert D Osterhaus; Oscar Pontesilli
Journal:  J Med Virol       Date:  2009-02       Impact factor: 2.327

9.  Activated plasmacytoid dendritic cells act synergistically with hepatitis B core antigen-pulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response.

Authors:  Weiwei Chen; Zheng Zhang; Ming Shi; Liangen Chen; Junliang Fu; Feng Shi; Bing Zhang; Hui Zhang; Lei Jin; Fu-Sheng Wang
Journal:  Clin Immunol       Date:  2008-09-06       Impact factor: 3.969

Review 10.  Immunological mechanisms of hepatitis B virus persistence in newborns.

Authors:  Nirupma Trehanpati; Syed Hissar; Shikha Shrivastav; Shiv K Sarin
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

View more
  3 in total

Review 1.  Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to Bedside.

Authors:  Sheikh Mohammad Fazle Akbar; Mamun Al Mahtab; Sakirul Khan; Osamu Yoshida; Julio Cesar Aguilar; Guillen Nieto Gerardo; Yoichi Hiasa
Journal:  Vaccines (Basel)       Date:  2022-05-10

2.  Biological effects of bone marrow mesenchymal stem cells on hepatitis B virus in vitro.

Authors:  Wei-Ping Zheng; Bo-Ya Zhang; Zhong-Yang Shen; Ming-Li Yin; Yi Cao; Hong-Li Song
Journal:  Mol Med Rep       Date:  2017-03-15       Impact factor: 2.952

3.  Chimeric Virus-Like Particles of Prawn Nodavirus Displaying Hepatitis B Virus Immunodominant Region: Biophysical Properties and Cytokine Response.

Authors:  Nathaniel Nyakaat Ninyio; Kok Lian Ho; Chean Yeah Yong; Hui Yee Chee; Muhajir Hamid; Hui Kian Ong; Abdul Razak Mariatulqabtiah; Wen Siang Tan
Journal:  Int J Mol Sci       Date:  2021-02-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.